Concepts (43)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptor, ErbB-3 | 2 | 2022 | 18 | 1.040 |
Why?
|
| Antigens, Viral | 2 | 2021 | 143 | 0.970 |
Why?
|
| Receptor, ErbB-2 | 2 | 2022 | 223 | 0.920 |
Why?
|
| Antibodies, Viral | 2 | 2021 | 293 | 0.880 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2021 | 7 | 0.790 |
Why?
|
| Immunization | 1 | 2021 | 158 | 0.760 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2021 | 262 | 0.720 |
Why?
|
| Immunoglobulin G | 2 | 2021 | 456 | 0.720 |
Why?
|
| Antibodies, Monoclonal | 2 | 2022 | 1376 | 0.630 |
Why?
|
| Laryngeal Neoplasms | 1 | 2006 | 89 | 0.260 |
Why?
|
| Airway Obstruction | 1 | 2006 | 109 | 0.250 |
Why?
|
| Trastuzumab | 1 | 2022 | 68 | 0.210 |
Why?
|
| Tetanus Toxoid | 1 | 2021 | 10 | 0.200 |
Why?
|
| Cross Protection | 1 | 2021 | 8 | 0.200 |
Why?
|
| Hybridomas | 1 | 2021 | 74 | 0.200 |
Why?
|
| Cross Reactions | 1 | 2021 | 106 | 0.200 |
Why?
|
| Antibody Formation | 1 | 2021 | 171 | 0.200 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 231 | 0.170 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1805 | 0.140 |
Why?
|
| Age Factors | 1 | 2021 | 1851 | 0.140 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 724 | 0.140 |
Why?
|
| Cell Line, Tumor | 1 | 2022 | 2426 | 0.140 |
Why?
|
| Postoperative Complications | 1 | 2006 | 2207 | 0.130 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 930 | 0.130 |
Why?
|
| Biomarkers | 1 | 2021 | 1718 | 0.120 |
Why?
|
| Humans | 5 | 2022 | 86643 | 0.100 |
Why?
|
| Middle Aged | 3 | 2021 | 25028 | 0.080 |
Why?
|
| Mice | 1 | 2022 | 11352 | 0.080 |
Why?
|
| Atropine | 1 | 2006 | 59 | 0.070 |
Why?
|
| Hemoptysis | 1 | 2006 | 24 | 0.070 |
Why?
|
| Bradycardia | 1 | 2006 | 39 | 0.070 |
Why?
|
| Fiber Optic Technology | 1 | 2006 | 35 | 0.070 |
Why?
|
| Bronchodilator Agents | 1 | 2006 | 65 | 0.070 |
Why?
|
| Tracheostomy | 1 | 2006 | 42 | 0.070 |
Why?
|
| Male | 3 | 2021 | 40965 | 0.070 |
Why?
|
| Intubation, Intratracheal | 1 | 2006 | 144 | 0.060 |
Why?
|
| Aged | 1 | 2021 | 18415 | 0.060 |
Why?
|
| Animals | 1 | 2022 | 26582 | 0.050 |
Why?
|
| Nucleocapsid | 1 | 2021 | 3 | 0.050 |
Why?
|
| Iran | 1 | 2021 | 15 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 40 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2021 | 154 | 0.050 |
Why?
|
| Female | 2 | 2021 | 44532 | 0.050 |
Why?
|